SENATE PASSES PHARMACEUTICAL ACCESS, COSTS AND TRANSPARENCY (PACT) ACT 3.0 

Bill continues Senate’s work to lower prescription drug costs,  promote transparency, and increase patient access   BOSTON (11/15/2023) — Today, the Massachusetts Senate unanimously passed the bipartisan Act Relative to Pharmaceutical Access, Costs, and Transparency, otherwise known as the PACT Act 3.0. The legislation would make urgent and much-needed reforms to the pharmaceutical system in the … Continue reading SENATE PASSES PHARMACEUTICAL ACCESS, COSTS AND TRANSPARENCY (PACT) ACT 3.0